NCT03210376View on ClinicalTrials.gov

Neuromuscular Blockade on Shoulder Pain of Elderly

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 17, 2017

Primary Completion Date

September 30, 2018

Study Completion Date

October 22, 2020

Conditions
Malignant Neoplasms of Digestive OrgansMalignant Neoplasms of Female Genital OrgansMalignant Neoplasms of Male Genital OrgansMalignant Neoplasms of Urinary Tract
Interventions
DRUG

Deep Neuromuscular Blockade (NMB)

Deep Neuromuscular Blockade (NMB) given during surgery.

DRUG

Moderate Neuromuscular Blockade (NMB)

Moderate Neuromuscular Blockade (NMB) given during surgery.

DRUG

Sugammadex

4 mg/Kg, intravenously as a single bolus injection after surgery.

DRUG

Neostigmine

70 mcg/Kg up to a total of 5 mg, intravenously slowly over a period of at least 1 minute after surgery.

BEHAVIORAL

Pain Assessment

Pain assessment done at about 15, 45, and 90 minutes after surgery.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER

NCT03210376 - Neuromuscular Blockade on Shoulder Pain of Elderly | Biotech Hunter | Biotech Hunter